Synthesis, cytotoxicity and docking studies (with SARS-CoV-2) of water-soluble binuclear Ru--cymene complex holding indole thiosemicarbazone ligand.

A water-soluble binuclear organometallic Ru--cymene complex [Ru(η--cymene)(η-L)] () was prepared from ()-2-((1H-indol-3-yl)methylene)--phenylhydrazine-1-carbothioamide (HL) and [RuCl(cymene)] in methanol at room temperature under inert atmosphere. The structure of binuclear complex was analyzed by UV-Visible, FT-IR, NMR and mass spectroscopic methods. The solid-state structure of the complex was ascertained by single crystal X-ray diffraction technique. The complex exhibited -octahedral (piano-stool) geometry around Ru(II) ion. The cytotoxic property of the ligand and complex along with cisplatin was investigated against A549-lung, MCF-7-breast, HeLa-cervical, HepG-2-liver, T24-urinary bladder and EA.hy926-endothelial cancer cells, and Vero-kidney epithelial normal cells. The complex exhibited superior activity than cisplatin against A549, HeLa and T24 cancer cells with the IC values of 7.70, 11.2, and 5.05 µM, respectively. The complexes were cytotoxic specifically to the cancer cells. Molecular docking studies showed good binding potential of the ligand and complex with the spike protein and main protease of SARS-CoV-2, indicating the promising role of these compounds as antiviral compounds.